Претраживање
Приказ резултата 31-40 од 88
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
1-Hz repetitive transcranial magnetic stimulation and diphasic dyskinesia in Parkinson's disease
(Wiley-Blackwell, Hoboken, 2013)
Developmental relationship between language and joint attention in late talkers
(Pergamon-Elsevier Science Ltd, Oxford, 2013)
The article examines the relationship between expressive and receptive language and joint attention (JA) bids during language acquisition in late-talking children. The research was designed to be a longitudinal study with ...
A large-scale study of the Trichinella genus in the golden jackal (Canis aureus) population in Serbia
(Elsevier Science Bv, Amsterdam, 2015)
Over the last decades the golden jackal (Canis aureus) has significantly expanded its range throughout Southeast and Central Europe, and the Balkan Peninsula is considered to be a core area of the species distribution in ...
Gene and protein expression analyses of the mtor signaling pathway in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2015)
Factors associated with Toxoplasma gondii infection in confined farrow-to-finish pig herds in western France: an exploratory study in 60 herds
(Biomed Central Ltd, London, 2016)
Background: Infection by Toxoplasma gondii postnatally can occur after ingestion of contaminated meat or water (tissue cysts/oocysts). In Europe, percentage of meat borne infections is estimated between 30 and 63 %, out ...
Proangiogenetic molecules vegf, hif-1alpha and enos in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2013)
Cd38 and interleukin 6 gene polymorphism in b-cell chronic lymphocytic leukemia-correlation with clinical and laboratory parametars
(Ferrata Storti Foundation, Pavia, 2016)
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
(Amer Soc Hematology, Washington, 2019)
Increased energy requirement and metabolic reprogramming are hallmarks of cancer cells. We show that metabolic alterations in hematopoietic cells are fundamental to the pathogenesis of mutant JAK2-driven myeloproliferative ...
Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)